MedPath
NMPA Product

Rezivertinib Mesylate Capsules

Product approved by National Medical Products Administration (CN)

Basic Information

Rezivertinib Mesylate Capsules

甲磺酸瑞齐替尼胶囊

瑞必达

30mg(按C₂₇H₃₀N₆O₃计)

胶囊剂

Regulatory Information

国药准字H20240017

Approved

化学药品

May 15, 2024

Company Information

Active Ingredients

© Copyright 2025. All Rights Reserved by MedPath